Orsero (ORS) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
26 Dec, 2025Executive summary
Achieved all 2024 financial and ESG targets, with net sales up 2% to €1,571.3 million, adjusted EBITDA at €83.7 million (5.3% margin), and adjusted net profit at €31.5 million, despite margin normalization and market volatility.
Distribution BU drove growth, especially in Q4, while Shipping BU normalized after exceptional prior years.
High-value product segments (kiwifruit, table grapes, avocados, berries) offset lower banana and shipping margins.
Proposed cash dividend of €0.50 per share for approval at the next AGM.
Results met or exceeded revised guidance.
Financial highlights
Net financial position improved to €111.2 million (including IFRS 16), better than guidance and down from €127.8 million in 2023; NFP excluding IFRS 16 at €54.8 million.
Adjusted EBITDA was €83.7 million, down 21.9% year-over-year, with margin at 5.3% (down from 7.0% in 2023).
Adjusted EBIT reached €48.7 million; adjusted net profit at €31.5 million, both at the high end of guidance.
Net sales grew 2% year-over-year, with Distribution up 3% and Shipping down 12.6%.
Cash and cash equivalents at year-end were €85.4 million.
Outlook and guidance
FY 2025 guidance: net sales €1,580–1,640 million; adjusted EBITDA €77–82 million; adjusted net profit €26–30 million; NFP €110–105 million; capex €15–17 million.
ESG targets for 2025 include 100% of market stands and employees involved in sustainability initiatives and food safety certification.
Guidance remains conservative due to working capital absorption and non-recurring positive effects in 2024.
Forex volatility and sourcing challenges expected; hedging strategies in place.
Banana business faces intense competition.
Latest events from Orsero
- FY 2025 exceeded guidance with strong growth, margins, and a proposed €0.61 dividend.ORS
Q4 202513 Mar 2026 - Double-digit revenue and profit growth in H1 2025 led to an upward revision of FY guidance.ORS
Q2 20253 Feb 2026 - Net sales and EBITDA declined, but Q2 Distribution outperformed and cash flow stayed robust.ORS
H1 202420 Jan 2026 - Stable revenues and strong distribution offset profit decline; FY 2024 guidance confirmed.ORS
Q3 202413 Jan 2026 - Q1 2025 net sales up 12.6%, EBITDA up 28%, guidance and dividend confirmed.ORS
Q1 202526 Nov 2025 - Strong revenue and profit growth in 9M 2025, with guidance confirmed at the upper end.ORS
Q3 202514 Nov 2025